This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Micurx Pharmaceuticals, Inc., Shanghai Micurx Pharmaceutical Co., Ltd.. Active years: 2013-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2024
Title: The Innovative Contributions of Jinqian Liu
Introduction
Jinqian Liu is a prominent inventor based in Fremont, California, known for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Liu has made remarkable advancements in the development of antimicrobial agents and pharmaceutical crystals.
Latest Patents
Liu's latest patents include a pharmaceutical crystal of contezolid acefosamil, which details a preparation method and its various uses. This invention focuses on a crystal or crystal complex of formula I, where R can be hydrogen, sodium, or a mixture thereof in any ratio. Another notable patent is for antimicrobial polymyxins aimed at treating bacterial infections. This invention provides antimicrobial polymyxin compounds that serve as antibacterial agents, along with pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Career Highlights
Throughout his career, Jinqian Liu has worked with notable companies such as Micurx Pharmaceuticals, Inc. and Shanghai Micurx Pharmaceutical Co., Ltd. His work in these organizations has contributed to the advancement of pharmaceutical research and development.
Collaborations
Liu has collaborated with esteemed colleagues, including Mikhail Fedorovich Gordeev and Xinghai Wang, further enhancing the impact of his innovative work in the pharmaceutical industry.
Conclusion
Jinqian Liu's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a dedication to developing effective treatments for bacterial infections and improving pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile